Negara: Australia
Bahasa: Inggris
Sumber: Department of Health (Therapeutic Goods Administration)
moxifloxacin hydrochloride monohydrate
Apotex Pty Ltd
moxifloxacin hydrochloride
Registered
MOXIFLOXACIN APOTEX _Contains the active ingredient moxifloxacin (as hydrochloride monohydrate)_ CONSUMER MEDICINE INFORMATION _FOR A COPY OF A LARGE PRINT LEAFLET, PH: 1800 195 055_ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT THIS MEDICINE IS USED FOR This medicine contains the active ingredient moxifloxacin, which is an antibiotic belonging to a group of medicines called quinolones. These antibiotics work by killing the bacteria that are causing your infection. Moxifloxacin will not work against infections caused by viruses such as colds or the flu. It is used to treat infections of the lungs, airways and sinuses in adults. In certain infections, you may require treatment with moxifloxacin injection followed by a course of moxifloxacin tablets e.g. severe and complicated skin and skin structure infections. Even if you have read the Consumer Medicine Information for moxifloxacin injection, you should read this leaflet as well as it contains information specific to the tablets. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed this medicine for another reason. This medicine is available only with a doctor's prescription. There is no evidence that this medicine is addictive. This medicine should not be used in children and adolescents under 18 years of age. BEFORE YOU TAKE THIS MEDICINE _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE THIS MEDICINE IF YOU HAVE AN ALLERGY TO: • moxifloxacin or other medicines belonging to the quinolone family (e.g. ciprofloxacin, norfloxacin or n Baca dokumen lengkapnya
1 AUSTRALIAN PRODUCT INFORMATION MOXIFLOXACIN APOTEX (MOXIFLOXACIN (AS HYDROCHLORIDE MONOHYDRATE)) TABLET 1 NAME OF THE MEDICINE Moxifloxacin (as hydrochloride monohydrate). 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet contains 400 mg of moxifloxacin (as hydrochloride monohydrate) as the active ingredient. For the full list of excipients see section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM 400 MG TABLET: Reddish brown coloured, modified capsule-shaped, biconvex film coated tablet engraved “APO” on one side and “MX 400” on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Moxifloxacin tablets are indicated for the treatment of adults with infections caused by susceptible organisms in the conditions: • Acute bacterial sinusitis • Community acquired pneumonia • Acute exacerbations of chronic bronchitis Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. Therapy with moxifloxacin may be initiated, in some conditions, before results of these tests are known. Once results become available, therapy should be continued with the most appropriate antibiotic therapy. Consideration should be given to available official guidance on the appropriate use of antibacterial agents. 4.2 DOSE AND METHOD OF ADMINISTRATION MOXIFLOXACIN APOTEX film coated tablets are intended for oral administration. DOSAGE The usual dose of moxifloxacin is 400 mg orally or intravenously every 24 hours. The recommended dose should not be exceeded. NOTE: a moxifloxacin intravenous solution is not available in this brand. The duration of therapy depends on the type of infection as described below. 2 INFECTION DAILY DOSE USUAL DURATION Acute bacterial sinusitis 400 mg 10 days (oral therapy) Acute bacterial exacerbations of chronic bronchitis 400 mg 5 days (sequential IV/oral therapy*, oral therapy) Community acquired pneumonia 400 mg 10 days (oral therapy) Baca dokumen lengkapnya